Physician profile
Junhong Gui
NPI 1922437169
$1,256.00
in general payments reported to CMS, 2019-2025
18 companies · $38.15 in 2025
The $38.15 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $365 · 2021: $324 · 2022: $37.74 · 2025: $38.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $322.36 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $269.59 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $122.21 | 2021-2022 | |
| Boston Scientific Corporation | $93.58 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.27 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.12 | 2019-2021 | |
| Amgen INC. | $50.30 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $44.88 | 2020-2021 | |
| Lundbeck LLC | $30.57 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $26.22 | 2019 | |
| Abbott Laboratories | $25.60 | 2021 | |
| Pfizer INC. | $21.10 | 2025 | |
| Amarin Pharma, INC. | $19.90 | 2020 | |
| Aegerion Pharmaceuticals, INC. | $18.41 | 2019 | |
| Cvrx, INC. | $17.05 | 2025 | Barostim Neo System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.86 | 2021 | |
| Kestra Medical Technology Services, INC. | $13.18 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Junhong Gui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.